Remember that much-hyped story about an Australian tech entrepreneur using ChatGPT, Grok, and other AI tools to craft a personalized cancer vaccine for his dog? Well, surprise: he's launched a startup. That entrepreneur is Paul Conyngham, who says he is launching Gamgee to offer "personalised mRNA c...
Remember that much-hyped story about an Australian tech entrepreneur using ChatGPT, Grok, and other AI tools to craft a personalized cancer vaccine for his dog? Well, surprise: he's launched a startup.
That entrepreneur is Paul Conyngham, who says he is launching Gamgee to offer "personalised mRNA cancer vaccines for dogs." But his ambitions go well beyond dogs - and pets - with Gamgee's website promising the company will harness AI and genetics to develop personalized treatments for a range of diseases and species, including humans.
At the center of Gamgee's origin story is Rosie, Conyngham's Staffordshire bull terrier-Shar Pei mix, who …
This story was first published by The Verge. Read the original report
We use cookies to run this site and, with your consent, to measure traffic and improve our content. Necessary cookies are always on. You can accept all cookies or choose which ones to allow. Privacy policy.